Status:
COMPLETED
Economic Evaluation of Systemic Treatments for Moderate-to-severe Psoriasis
Lead Sponsor:
Jochen Schmitt.
Collaborating Sponsors:
Merck Sharp & Dohme LLC
Conditions:
Psoriasis
Eligibility:
All Genders
16-65 years
Brief Summary
This study is health economic analysis of medicinal treatment options for moderate-to-severe psoriasis vulgaris from the societal perspective. Efficacy data and other clinical outcomes will be derived...
Eligibility Criteria
Inclusion
- diagnosis of moderate-to-severe psoriasis
Exclusion
- \-
Key Trial Info
Start Date :
March 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2014
Estimated Enrollment :
1 Patients enrolled
Trial Details
Trial ID
NCT01812954
Start Date
March 1 2013
End Date
June 1 2014
Last Update
August 11 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.